IGF-1 DES: Deep Dive: How It Works, Who Uses It, and Safety Profile
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
> # IGF-1 DES: Deep Dive: How It Works, Who Uses It, and Safety Profile > > IGF-1 DES, also known as Des(1-3)IGF-1, is a truncated version of Insulin-like Growth Factor 1 (IGF-1) It is a naturally occurring variant of IGF-1 that has been found in various tissues, including the brain and gastrointestinal tract.
> # IGF-1 DES: Deep Dive: How It Works, Who Uses It, and Safety Profile
>
> IGF-1 DES, also known as Des(1-3)IGF-1, is a truncated version of Insulin-like Growth Factor 1 (IGF-1). It is a naturally occurring variant of IGF-1 that has been found in various tissues, including the brain and gastrointestinal tract. What makes IGF-1 DES particularly interesting is its increased potency compared to standard IGF-1. This article provides a deep dive into IGF-1 DES, exploring its mechanism of action, its users, and its safety profile.
>
> ## A More Potent, Site-Specific Variant
>
> IGF-1 DES is a shorter version of the IGF-1 molecule, lacking the first three amino acids at its N-terminus. This seemingly small modification has a significant impact on its biological activity. The N-terminus of IGF-1 is involved in binding to Insulin-like Growth Factor Binding Proteins (IGFBPs), which are proteins that circulate in the bloodstream and regulate the activity of IGF-1. By lacking this binding domain, IGF-1 DES has a much lower affinity for IGFBPs. This means that more of it is available in its free, active form to bind to the IGF-1 receptor on cells, resulting in a significantly higher potency – estimated to be around 10 times that of standard IGF-1 [1].
>
> Another key characteristic of IGF-1 DES is its short half-life, which is only a few minutes. This makes it a highly site-specific peptide, meaning it exerts its effects primarily in the area where it is administered. This is in contrast to IGF-1 LR3, which has a much longer half-life and more systemic effects.
>
> ## Who Uses IGF-1 DES and Why?
>
> The unique properties of IGF-1 DES have made it a popular choice among bodybuilders and athletes for specific applications.
>
> Localized Muscle Growth: Due to its site-specific nature, IGF-1 DES is often used to target specific, lagging muscle groups. It is typically injected directly into the muscle that the user wants to grow, with the belief that it will stimulate localized hyperplasia (the creation of new muscle cells).
> Pre-Workout Boost: Some users administer IGF-1 DES shortly before a workout. The theory is that the increased potency and localized action will enhance nutrient partitioning to the working muscles, leading to a better pump and improved performance.
>
> ## Researched Benefits and Potential Applications
>
> While much of the use of IGF-1 DES is in the realm of performance enhancement, research has also explored its potential therapeutic applications.
>
> Wound Healing: The potent, localized action of IGF-1 DES could make it a valuable tool for accelerating wound healing and tissue repair [2].
> Gastrointestinal Health: IGF-1 DES is naturally found in the gastrointestinal tract and is believed to play a role in gut health and repair. It has been investigated as a potential treatment for conditions like inflammatory bowel disease [3].
> Neurological Effects: IGF-1 DES is also found in the brain, and research suggests it may have neuroprotective and cognitive-enhancing effects [4].
>
> ## Safety Profile and Risks
>
> As with any potent, anabolic substance, the use of IGF-1 DES is not without risks.
>
> Hypoglycemia: Like other forms of IGF-1, IGF-1 DES can cause a drop in blood sugar levels, which can be dangerous if not managed properly.
> Unknown Long-Term Effects: The long-term consequences of using high doses of IGF-1 DES are not well understood.
> Black Market Products: As a non-FDA-approved substance, IGF-1 DES is sourced from the black market, which carries risks related to product quality, purity, and sterility.
> | Parameter | Value |
> | :--- | :--- |
> | Administration | Intramuscular or Subcutaneous injection |
> | Typical Dose | 20-50 mcg, often split into multiple daily injections |
> | Cycle Length | Short cycles of 2-4 weeks are common |
> ## Key Takeaways
>
> IGF-1 DES is a truncated, more potent version of IGF-1 with a short half-life.
> It is used by bodybuilders for localized muscle growth and as a pre-workout supplement.
> Research has explored its potential for wound healing, gut health, and neurological applications.
> The use of IGF-1 DES carries risks, including hypoglycemia and the dangers associated with black market products.
>
> > Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.
>
> ## References
>
> [1] Ballard, F. J., Wallace, J. C., Francis, G. L., Read, L. C., & Tomas, F. M. (1996). Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I. International journal of biochemistry & cell biology, 28(10), 1085-1087. https://pubmed.ncbi.nlm.nih.gov/8930132/
>
> [2] Xian, C. J., Cool, J. C., & Schalkwyk, D. A. (2008). Local actions of IGF-I and its analogues in stimulating bone and cartilage regeneration. Journal of musculoskeletal & neuronal interactions, 8(4), 328-329. https://www.ncbi.nlm.nih.gov/pubmed/19147959
>
> [3] Howarth, G. S., & Xian, C. J. (2009). Insulin-like growth factor-I and the gastrointestinal system: therapeutic prospects and challenges. Expert review of gastroenterology & hepatology, 3(3), 277-287. https://www.tandfonline.com/doi/abs/10.1586/egh.09.18
>
> [4] Guan, J., Bennet, L., Gluckman, P. D., & Gunn, A. J. (2003). Insulin-like growth factor-1 and the developing brain. Early human development, 71(2), 133-147. https://www.sciencedirect.com/science/article/abs/pii/S037837820200117X
---